[go: up one dir, main page]

TR200000726T2 - Budesonid ve formoterol'ün yeni kullanımı. - Google Patents

Budesonid ve formoterol'ün yeni kullanımı.

Info

Publication number
TR200000726T2
TR200000726T2 TR2000/00726T TR200000726T TR200000726T2 TR 200000726 T2 TR200000726 T2 TR 200000726T2 TR 2000/00726 T TR2000/00726 T TR 2000/00726T TR 200000726 T TR200000726 T TR 200000726T TR 200000726 T2 TR200000726 T2 TR 200000726T2
Authority
TR
Turkey
Prior art keywords
formoterol
budesonide
new use
bulus
treatment
Prior art date
Application number
TR2000/00726T
Other languages
English (en)
Inventor
Bauer Carl-Axel
Trofast Jan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200000726(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200000726T2 publication Critical patent/TR200000726T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bulus, formoterol ve budesonidin kronik obstruktif pulmoner hastaliklarin tedavisinde kullanimini temin eder.
TR2000/00726T 1997-09-19 1998-09-09 Budesonid ve formoterol'ün yeni kullanımı. TR200000726T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use

Publications (1)

Publication Number Publication Date
TR200000726T2 true TR200000726T2 (tr) 2000-09-21

Family

ID=20408325

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00726T TR200000726T2 (tr) 1997-09-19 1998-09-09 Budesonid ve formoterol'ün yeni kullanımı.

Country Status (38)

Country Link
US (2) US7897646B2 (tr)
EP (2) EP1014993B1 (tr)
JP (1) JP2001517630A (tr)
KR (1) KR20010024140A (tr)
CN (1) CN1149998C (tr)
AR (1) AR013506A1 (tr)
AT (2) ATE329599T1 (tr)
AU (1) AU757235B2 (tr)
BR (1) BR9812325A (tr)
CA (1) CA2302700C (tr)
CY (1) CY1106156T1 (tr)
CZ (1) CZ295250B6 (tr)
DE (2) DE69807239T2 (tr)
DK (2) DK1014993T3 (tr)
EE (1) EE04297B1 (tr)
ES (2) ES2266322T3 (tr)
HK (1) HK1045812B (tr)
HU (1) HUP0003848A2 (tr)
ID (1) ID24838A (tr)
IL (1) IL134773A (tr)
IN (1) IN190791B (tr)
IS (1) IS2715B (tr)
MX (1) MXPA00002615A (tr)
MY (1) MY127812A (tr)
NO (1) NO327176B1 (tr)
NZ (1) NZ503173A (tr)
PL (1) PL190782B1 (tr)
PT (2) PT1210943E (tr)
RU (1) RU2199322C2 (tr)
SA (1) SA98190773B1 (tr)
SE (1) SE9703407D0 (tr)
SI (2) SI1014993T1 (tr)
SK (1) SK285330B6 (tr)
TR (1) TR200000726T2 (tr)
TW (1) TW546140B (tr)
UA (1) UA72446C2 (tr)
WO (1) WO1999015182A1 (tr)
ZA (1) ZA988516B (tr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
EP2266548B1 (de) * 1998-11-13 2020-05-20 Jagotec AG Trockenpulver zur inhalation
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
CN1694689A (zh) * 2002-09-30 2005-11-09 阿库斯菲尔公司 供吸入的缓释多孔微粒
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1921919B1 (en) * 2005-07-14 2012-04-04 Lithera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
JP2009519970A (ja) * 2005-12-15 2009-05-21 アキュスフィア， インコーポレイテッド 粒子ベースの経口投与用製薬剤形の製造方法
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
US20100119609A1 (en) * 2006-10-17 2010-05-13 John Daniel Dobak Methods, compositions, and formulations for the treatment of thyroid eye disease
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL2435025T3 (pl) 2009-05-29 2017-08-31 Pearl Therapeutics, Inc. Dostarczanie substancji czynnych do dróg oddechowych
WO2010144628A2 (en) * 2009-06-09 2010-12-16 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
KR101638301B1 (ko) * 2010-01-15 2016-07-08 네오쎄틱스 인코포레이티드 동결건조 케이크 제제
GEP201606551B (en) 2010-11-24 2016-10-10 Novamedica Llc Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
EP3556348B1 (en) 2015-12-04 2021-02-03 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CA3103679A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis
US12329759B2 (en) 2019-10-17 2025-06-17 Trustees Of Boston University Methods and compositions relating to lung function

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235222A (en) 1989-09-08 1992-11-25 Glaxo Group Ltd Inhalatory composition comprising salmeterol and beclomethasone dipropionate
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
EP1101493A3 (en) 1991-12-18 2004-01-14 AstraZeneca AB New combination of formoterol and budesonide
DE69232462T2 (de) * 1991-12-18 2002-10-10 Astrazeneca Ab, Soedertaelje Formoterol und budesonide enthaltende zusammensetzung
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
CA2238298A1 (en) * 1995-11-24 1997-06-19 Luca Francesco Raveglia Quinoline derivatives
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
BR9810452A (pt) 1997-06-27 2000-09-05 Astra Ab Nova combinação de medicamentos contra asma
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
KR20010024140A (ko) 2001-03-26
IS5407A (is) 2000-03-15
TW546140B (en) 2003-08-11
JP2001517630A (ja) 2001-10-09
CY1106156T1 (el) 2011-06-08
AU757235B2 (en) 2003-02-06
MY127812A (en) 2006-12-29
ES2266322T3 (es) 2007-03-01
ID24838A (id) 2000-08-24
WO1999015182A1 (en) 1999-04-01
US20020042404A1 (en) 2002-04-11
UA72446C2 (uk) 2005-03-15
EE04297B1 (et) 2004-06-15
NZ503173A (en) 2001-08-31
DK1014993T3 (da) 2002-11-11
SE9703407D0 (sv) 1997-09-19
ATE222106T1 (de) 2002-08-15
HUP0003848A2 (hu) 2001-08-28
IL134773A0 (en) 2001-04-30
IL134773A (en) 2005-03-20
RU2199322C2 (ru) 2003-02-27
DE69834955T2 (de) 2007-01-25
IN190791B (tr) 2003-08-23
DE69807239T2 (de) 2003-04-10
DE69807239D1 (de) 2002-09-19
DE69834955D1 (de) 2006-07-27
ZA988516B (en) 1999-03-19
SK3892000A3 (en) 2000-12-11
SK285330B6 (sk) 2006-11-03
DK1210943T3 (da) 2006-09-18
IS2715B (is) 2011-02-15
PL339295A1 (en) 2000-12-04
HK1045812A1 (en) 2002-12-13
PT1210943E (pt) 2006-09-29
PT1014993E (pt) 2002-12-31
SI1014993T1 (en) 2003-02-28
NO20001401D0 (no) 2000-03-17
CZ295250B6 (cs) 2005-06-15
MXPA00002615A (es) 2002-04-24
AU9192898A (en) 1999-04-12
AR013506A1 (es) 2000-12-27
CZ2000950A3 (cs) 2000-06-14
SI1210943T1 (sl) 2006-10-31
NO20001401L (no) 2000-03-17
EP1014993A1 (en) 2000-07-05
US20110097282A1 (en) 2011-04-28
HK1045812B (en) 2006-12-22
CA2302700A1 (en) 1999-04-01
EP1210943B1 (en) 2006-06-14
US8461211B2 (en) 2013-06-11
SA98190773B1 (ar) 2006-10-02
EP1210943A1 (en) 2002-06-05
BR9812325A (pt) 2000-09-05
NO327176B1 (no) 2009-05-04
EP1014993B1 (en) 2002-08-14
US7897646B2 (en) 2011-03-01
PL190782B1 (pl) 2006-01-31
CN1149998C (zh) 2004-05-19
ATE329599T1 (de) 2006-07-15
ES2182357T3 (es) 2003-03-01
CN1271287A (zh) 2000-10-25
EE200000145A (et) 2001-02-15
CA2302700C (en) 2010-11-23
US20060189587A9 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
TR200000726T2 (tr) Budesonid ve formoterol'ün yeni kullanımı.
Gorrieri et al. Action refinement
DE69721766D1 (de) Neue arzneiformulierung
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
ID27606A (id) Penghantaran raloksifen secara pulmonary dan nasal
DE69625926D1 (de) Absorbierende zusammensetzung und saugfähiges wegwerfkleidungsstück, welches dasselbe enthält
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ID23600A (id) Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453)
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
IT1307047B1 (it) Apparecchiatura per il trattamento umidificato dell'apnea da sonno.
IS5756A (is) Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
CA2195093A1 (en) Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
ID30116A (id) Turunan-turunan piridopiranoazepin, pembuatannya dan penggunaan terapinya
MXPA03008739A (es) Anticuerpos recombinantes asociados a gangliosidos. su uso en el diagnostico y tratamiento de tumores.
DE69324826D1 (de) Gegen Papillomaviren wirksame 2',5'-OLIGOADENYLAT-2',3'-CYCLOPHOSPHATE und 2',5'-OLIGOADENYLATE
EP0675120A3 (en) Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
FI956298L (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO991619D0 (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
PL345325A1 (en) Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
MD980129A (en) Antiherpetic remedy
FI965172A7 (fi) Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
FR2728596B1 (fr) Degrilleur, notamment du type courbe
MANZAI The Home-cared Role of Physiatrists Who Work in Rehabilitation Center and Other Official Hospital
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon